US Patent Issued to Sapience Therapeutics on Jan. 28 for "ATF5 peptide variants and uses thereof" (New York, Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,131, issued on Jan. 28, was assigned to Sapience Therapeutics Inc. (Tarrytown, N.Y.).

"ATF5 peptide variants and uses thereof" was invented by Barry Jay Kappel (Pelham, N.Y.), Gene Merutka (Phoenixville, Pa.) and Jimmy Andrew Rotolo (Port Washington, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are ATF5 peptides having a truncated ATF5 leucine zipper region and, optionally, a cell-penetrating region, compositions comprising the ATF5 peptides, and methods of inhibiting proliferation of and promoting cytotoxicity in a neoplastic cell using the ATF5 peptides."

The patent was filed on Dec. 9, 2023, under Application No. 18/534,620.

*Fo...